Literature DB >> 26323186

Understanding and Avoiding Immortal-Time Bias in Gastrointestinal Observational Research.

Laura E Targownik1,2, Samy Suissa1,2.   

Abstract

Pharmacoepidemiologic analyses, in which observational data is interrogated to evaluate relationships between patterns of drug use and both beneficial and adverse outcomes, are being increasingly used in the study of inflammatory bowel disease. However, the results of many of these analyses may be corrupted by the presence of immortal person-time bias, an analytic error which can result in an overestimation of the benefits of medical therapy. In this report, we will describe immortal person-time bias, explain the mechanism through which it confers a false benefit, and guide the reader in how to identify this source of bias in the medical literature.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26323186     DOI: 10.1038/ajg.2015.210

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  15 in total

1.  Randomized, controlled trials, observational studies, and the hierarchy of research designs.

Authors:  J Concato; N Shah; R I Horwitz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

Review 2.  Time-dependent covariates in the Cox proportional-hazards regression model.

Authors:  L D Fisher; D Y Lin
Journal:  Annu Rev Public Health       Date:  1999       Impact factor: 21.981

3.  Immortal time bias in estimates of mortality among infliximab-treated patients with Crohn's disease.

Authors:  James D Lewis
Journal:  Gut       Date:  2010-08-23       Impact factor: 23.059

4.  Response to Targownik.

Authors:  Fernando Magro; Eduardo Rodrigues-Pinto; Rosa Coelho; Patrícia Andrade; João Santos-Antunes; Susana Lopes; Claudia Camila-Dias; Guilherme Macedo
Journal:  Am J Gastroenterol       Date:  2015-02       Impact factor: 10.864

Review 5.  Limitations of the randomized controlled trial in evaluating population-based health interventions.

Authors:  Robert William Sanson-Fisher; Billie Bonevski; Lawrence W Green; Cate D'Este
Journal:  Am J Prev Med       Date:  2007-08       Impact factor: 5.043

Review 6.  Immortal time bias in pharmaco-epidemiology.

Authors:  Samy Suissa
Journal:  Am J Epidemiol       Date:  2007-12-03       Impact factor: 4.897

7.  Exclusion of immortal person-time.

Authors:  Kenneth J Rothman; Samy Suissa
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-10       Impact factor: 2.890

8.  Immortal time bias and infliximab-related mortality and malignancy incidence.

Authors:  Laura Ellyn Targownik
Journal:  Gut       Date:  2010-03       Impact factor: 23.059

9.  The importance of accounting for immortal time bias in pharmacoepidemiologic analyses.

Authors:  Laura Targownik
Journal:  Am J Gastroenterol       Date:  2015-02       Impact factor: 10.864

10.  Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.

Authors:  Fernando Magro; Eduardo Rodrigues-Pinto; Rosa Coelho; Patrícia Andrade; João Santos-Antunes; Susana Lopes; Claudia Camila-Dias; Guilherme Macedo
Journal:  Am J Gastroenterol       Date:  2014-05-06       Impact factor: 10.864

View more
  14 in total

1.  Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality.

Authors:  Aaron P Thrift; Yamini Natarajan; Yan Liu; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2019-01-06       Impact factor: 11.382

Review 2.  Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.

Authors:  Rebecca G Kim; Rohit Loomba; Larry J Prokop; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2017-05-04       Impact factor: 11.382

3.  Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.

Authors:  Steven F G Jeuring; Tim R A van den Heuvel; Limmie Y L Liu; Maurice P Zeegers; Wim H Hameeteman; Mariëlle J L Romberg-Camps; Liekele E Oostenbrug; Ad A M Masclee; Daisy M A E Jonkers; Marieke J Pierik
Journal:  Am J Gastroenterol       Date:  2016-12-06       Impact factor: 10.864

4.  Comment to: Ventral hernia recurrence in women of childbearing age: a systematic review and meta-analysis. T. Nouh, F. S. Ali, K. J. Krause, I. Zaimi.

Authors:  E Oma; K K Jensen; L N Jorgensen
Journal:  Hernia       Date:  2019-01-22       Impact factor: 4.739

5.  Association of cardiac implantable electronic devices with survival in bifascicular block and prolonged PR interval on electrocardiogram.

Authors:  Naeem Moulki; Jessica V Kealhofer; David G Benditt; Amy Gravely; Kairav Vakil; Santiago Garcia; Selcuk Adabag
Journal:  J Interv Card Electrophysiol       Date:  2018-06-16       Impact factor: 1.900

Review 6.  Does Metformin Reduce Cancer Risks? Methodologic Considerations.

Authors:  Asieh Golozar; Shuiqing Liu; Joeseph A Lin; Kimberly Peairs; Hsin-Chieh Yeh
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

7.  Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease.

Authors:  Ryan Ungaro; Helena L Chang; Justin Côté-Daigneault; Saurabh Mehandru; Ashish Atreja; Jean-Frederic Colombel
Journal:  Am J Gastroenterol       Date:  2016-06-14       Impact factor: 10.864

Review 8.  The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.

Authors:  Don Chamil Codipilly; Apoorva Krishna Chandar; Siddharth Singh; Sachin Wani; Nicholas J Shaheen; John M Inadomi; Amitabh Chak; Prasad G Iyer
Journal:  Gastroenterology       Date:  2018-02-16       Impact factor: 22.682

9.  Model-Based Estimates of Tumor Growth Inhibition Metrics Are Time-Independent: A Reply to Mistry.

Authors:  L Claret; K Han; R Bruno
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-04-11

10.  Quantifying the Costs of Transcatheter Aortic Valve Replacement Hesitancy.

Authors:  Santiago Garcia; Mario Gössl; Paul Sorajja
Journal:  J Am Heart Assoc       Date:  2018-09-18       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.